Centers for Disease Control and Prevention. (2011). Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report. 60(RR01):1-24.
This report provides recommendations for treatment and chemoprophylaxis of influenza virus infection. The authors identify populations at greater risk of complications, identify major changes from previous recommendations, describe the mechanism of virus transmission and the clinical signs and symptoms of disease, outline the role of laboratory diagnostics, and provide information on the four approved influenza antiviral agents, including their usage, dosage, adverse events, drug interactions, and possible emergency use authorization.